Paclitaxel-Induced Inhibition of NSCLC Invasion and Migration via RBFOX3-Mediated circIGF1R Biogenesis

Author:

Xu Zhanyu1,Zheng Liping1,Li Shikang1

Affiliation:

1. The First Affiliated Hospital of Guangxi Medical University

Abstract

Abstract Background: We previously reported that circIGF1R is significantly downregulated in non-small cell lung cancer (NSCLC) cells and tissues. It inhibits cancer cell invasion and migration, although the underlying molecular mechanisms remain elusive. Methods: The invasion and migration of NSCLC cells was analyzed by routine in vivo and in vitro functional assays. Fluorescent in situ hybridization, luciferase reporter assay, RNA pull-down assay and RNA immunoprecipitation (RIP) assay were performed to explore the molecular mechanisms. Mechanism of action of paclitaxel-induced RBFOX3-mediated inhibition of NSCLC invasion and migration was investigated through in vitro and in vivo experiments. Results: We found that circIGF1R regulated Van-Gogh-like 2 (VANGL2) expression as a Competing endogenous RNA (ceRNA) by “sponging” miR-1270, and inhibited the invasion and migration progression of NSCLC cells by inhibiting the Wnt pathway via the miR-1270/VANGL2 axis. Furthermore, RNA binding protein fox-1 homolog 3 (RBFOX3) promoted circIGF1R biogenesis through binding to the IGF1R pre-mRNA. RBFOX3 inhibits the migration and invasion ability of PC9 cells and A549 cells by increasing the biogenesis of circIGF1R. The chemotherapeutic drug paclitaxel inhibited NSCLC invasion and migration by inducing RBFOX3-mediated circIGF1R biogenesis. Conclusions: RBFOX3 inhibits the invasion and migration of NSCLC cells through the circIGF1R/ miR-1270/VANGL2 axis, circIGF1R has the potential to serve as a biomarker and therapeutic target for NSCLC.

Publisher

Research Square Platform LLC

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3